Robert Liptak, 10% Owner at TETRALOGIC PHARMACEUTICALS CORP (TLOG), bought 4,644,705 shares at $7.00 ($16.1M) on 2013-12-17, disclosed to the SEC on 2013-12-19.
Open-market purchase of $16.1M TLOG by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,342,944 | $0 | 0.0% |
| 2 | $6.40 | 23,282 | $149K | 0.9% |
| 3 | $7.00 | 853,416 | $6.0M | 37.1% |
| 4 | $7.00 | 1,425,063 | $10.0M | 62.0% |
| Total | $3.47 avg | 4,644,705 | $16.1M | 100% |
| Filing → |
| OXFD | SELL | 2015-03-24 | $774K | — | Filing → |
| AERI | SELL | 2015-01-06 | $729K | — | Filing → |
| AERI | SELL | 2014-12-30 | $2.4M | — | Filing → |